印度抗菌药物管理政策文件。
Policy document on antimicrobial stewardship practices in India.
机构信息
Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Department of Infectious Diseases, Apollo Hospitals, Chennai, India.
出版信息
Indian J Med Res. 2019 Feb;149(2):180-184. doi: 10.4103/ijmr.IJMR_147_18.
Abstract
Antimicrobial resistance (AMR) in India has become a great threat because of high rate of infectious diseases. One of the key contributing factors is high antibiotic use due to poor prescription practices, self-medication, over-the-counter sale of drugs and lack of awareness. Antimicrobial stewardship programme (AMSP) have been proved to be successful in restraining sale and use of antibiotics to a large extent in many countries. An AMSP programme for a hospital is imperative for rational and evidence-based antimicrobial therapy. The ultimate aim is to improve patient outcomes, reduce emergence of bacterial resistance and ensure longevity of the existing antimicrobials. The primary goal of AMSP is to encourage cautious use of available antibiotics by training the healthcare workers and creating awareness. This article describes the strategies and recommendations for formulation of AMSP policy for India.
摘要
印度的抗菌素耐药性（AMR）由于传染病发病率高而成为一个巨大的威胁。造成这种情况的一个关键因素是抗生素的大量使用，这是由于处方实践不当、自我用药、药物的非处方销售以及缺乏意识所致。抗菌药物管理计划（AMSP）已被证明在许多国家在很大程度上成功地限制了抗生素的销售和使用。为了实现合理和基于证据的抗菌治疗，医院的抗菌药物管理计划势在必行。其最终目标是改善患者的治疗效果，减少细菌耐药性的出现，并确保现有抗菌药物的有效性。抗菌药物管理计划的主要目标是通过培训医务人员和提高认识来鼓励谨慎使用现有的抗生素。本文介绍了制定印度抗菌药物管理计划政策的策略和建议。
相似文献
1
Policy document on antimicrobial stewardship practices in India.印度抗菌药物管理政策文件。
Indian J Med Res. 2019 Feb;149(2):180-184. doi: 10.4103/ijmr.IJMR_147_18.
2
A review of animal health and drug use practices in India, and their possible link to antimicrobial resistance.印度动物健康和药物使用情况综述及其与抗微生物药物耐药性的可能联系。
Antimicrob Resist Infect Control. 2020 Jul 8;9(1):103. doi: 10.1186/s13756-020-00760-3.
3
CMI policy on antimicrobial stewardship research.抗菌药物管理研究的CMI政策。
Clin Microbiol Infect. 2018 Feb;24(2):91-92. doi: 10.1016/j.cmi.2017.11.006. Epub 2017 Nov 10.
4
Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis.当前医院抗菌药物管理目标的证据：系统评价和荟萃分析。
Lancet Infect Dis. 2016 Jul;16(7):847-856. doi: 10.1016/S1473-3099(16)00065-7. Epub 2016 Mar 3.
5
The implementation and outcome of a 2-year prospective audit and feedback based antimicrobial stewardship program at a private tertiary care hospital.一家私立三级护理医院实施的一项为期两年的基于前瞻性审核与反馈的抗菌药物管理计划及其结果。
Indian J Med Microbiol. 2021 Oct-Dec;39(4):425-428. doi: 10.1016/j.ijmmb.2021.09.005. Epub 2021 Sep 22.
6
Antimicrobial stewardship programme (AMSP) practices in India.印度的抗菌药物管理计划（AMSP）实践。
Indian J Med Res. 2015 Aug;142(2):130-8. doi: 10.4103/0971-5916.164228.
7
Assessment of core capacities for antimicrobial stewardship practices in indian hospitals: Report from a multicentric initiative of global health security agenda.印度医院抗菌药物管理实践核心能力评估：全球卫生安全议程多中心倡议的报告
Indian J Med Microbiol. 2019 Jul-Sep;37(3):309-317. doi: 10.4103/ijmm.IJMM_19_445.
8
Antibiotics and adverse events: the role of antimicrobial stewardship programs in 'doing no harm'.抗生素与不良事件：抗菌药物管理项目在“不伤害”中的作用。
Curr Opin Infect Dis. 2019 Dec;32(6):553-558. doi: 10.1097/QCO.0000000000000604.
9
Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.微生物监测和抗菌药物管理策略可最大程度减少创伤重症监护病房医院获得性感染治疗中超广谱联合治疗的需求：基于证据的经验性抗菌药物政策的审核。
S Afr Med J. 2013 Mar 15;103(6):371-6. doi: 10.7196/samj.6459.
10
Antimicrobial stewardship: bridging the gap between quality care and cost.抗菌药物管理：弥合优质护理与成本之间的差距。
Curr Opin Infect Dis. 2011 Feb;24 Suppl 1:S11-20. doi: 10.1097/01.qco.0000393484.17894.05.
引用本文的文献
1
Correct sepsis classification-A must for antimicrobial stewardship: A longitudinal observational study.正确的脓毒症分类——抗菌药物管理的必备条件：一项纵向观察性研究。
World J Crit Care Med. 2025 Sep 9;14(3):101864. doi: 10.5492/wjccm.v14.i3.101864.
2
Recent insights into actinobacteria research in antimicrobial resistance: a review.近期放线菌抗微生物耐药性研究新进展：综述
Mol Biol Rep. 2025 Jul 8;52(1):683. doi: 10.1007/s11033-025-10797-5.
3
Antimicrobial resistance: Current challenges and future directions.抗菌药物耐药性：当前挑战与未来方向。
Med J Armed Forces India. 2025 May-Jun;81(3):247-258. doi: 10.1016/j.mjafi.2024.07.006. Epub 2024 Sep 19.
4
Etiological Profile and Antibiotic Susceptibility of Urinary Isolates Causing Urinary Tract Infections in Patients Attending a Tertiary Care Hospital in Rajkot, Gujarat.古吉拉特邦拉杰果德一家三级护理医院中引起尿路感染的尿液分离株的病因学特征及抗生素敏感性
Cureus. 2025 Apr 2;17(4):e81633. doi: 10.7759/cureus.81633. eCollection 2025 Apr.
5
Probing the in-depth analysis of Serious Adverse Drug Reactions in a tertiary care hospital of Central India.对印度中部一家三级护理医院严重药物不良反应进行深入分析的探究。
Explor Res Clin Soc Pharm. 2025 Feb 13;17:100579. doi: 10.1016/j.rcsop.2025.100579. eCollection 2025 Mar.
6
Adopting a model of antimicrobial stewardship program to anti-tubercular treatment stewardship: A single-centre experience from a private tertiary care hospital in South India.采用抗菌药物管理模式进行抗结核治疗管理：来自印度南部一家私立三级保健医院的单中心经验。
PLoS One. 2024 Nov 5;19(11):e0310493. doi: 10.1371/journal.pone.0310493. eCollection 2024.
7
Impact of Antimicrobial Stewardship on Reducing Antimicrobial Resistance.抗菌药物管理对降低抗菌药物耐药性的影响。
Cureus. 2023 Dec 4;15(12):e49935. doi: 10.7759/cureus.49935. eCollection 2023 Dec.
8
The Comparative Efficacy of Ceftazidime-Avibactam with or without Aztreonam vs Polymyxins for Carbapenem-resistant Enterobacteriaceae Infections: A Prospective Observational Cohort Study.头孢他啶-阿维巴坦联合或不联合氨曲南与多粘菌素治疗耐碳青霉烯类肠杆菌科细菌感染的疗效比较：一项前瞻性观察队列研究。
Indian J Crit Care Med. 2023 Dec;27(12):923-929. doi: 10.5005/jp-journals-10071-24577.
9
Awareness Regarding Antimicrobial Resistance and Antibiotic Prescribing Behavior among Physicians: Results from a Nationwide Cross-Sectional Survey in India.医生对抗菌素耐药性的认识及抗生素处方行为：印度全国横断面调查结果
Antibiotics (Basel). 2023 Sep 29;12(10):1496. doi: 10.3390/antibiotics12101496.
10
Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement.使用欧洲抗菌药物敏感性试验委员会（EUCAST）和临床与实验室标准协会（CLSI）折点进行抗菌药物敏感性试验的解读：一致性分析
Cureus. 2023 Mar 31;15(3):e36977. doi: 10.7759/cureus.36977. eCollection 2023 Mar.
本文引用的文献
1
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4.
2
Achieving global targets for antimicrobial resistance.实现抗菌药物耐药性的全球目标。
Science. 2016 Aug 26;353(6302):874-5. doi: 10.1126/science.aaf9286. Epub 2016 Aug 18.
3
Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014.2008 - 2014年印度一家大型私立实验室网络对血培养分离出的主要细菌病原体的抗生素耐药性趋势
Int J Infect Dis. 2016 Sep;50:75-82. doi: 10.1016/j.ijid.2016.08.002. Epub 2016 Aug 10.
4
Antimicrobial stewardship programme (AMSP) practices in India.印度的抗菌药物管理计划（AMSP）实践。
Indian J Med Res. 2015 Aug;142(2):130-8. doi: 10.4103/0971-5916.164228.
5
Success stories of implementation of antimicrobial stewardship: a narrative review.抗菌药物管理实施的成功案例：叙事性综述。
Clin Microbiol Infect. 2014 Oct;20(10):954-62. doi: 10.1111/1469-0691.12803. Epub 2014 Nov 14.
6
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data.全球抗生素消费 2000 年至 2010 年：国家药品销售数据分析。
Lancet Infect Dis. 2014 Aug;14(8):742-750. doi: 10.1016/S1473-3099(14)70780-7. Epub 2014 Jul 9.
7
Antimicrobial resistance in India: A review.印度的抗菌药物耐药性：综述
J Nat Sci Biol Med. 2013 Jul;4(2):286-91. doi: 10.4103/0976-9668.116970.
8
Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs?抗菌药物管理项目是否值得采摘“低垂的果实”？
Clin Infect Dis. 2012 Aug;55(4):587-92. doi: 10.1093/cid/cis494. Epub 2012 May 21.
9
Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).美国医疗机构流行病学学会（SHEA）、美国传染病学会（IDSA）和儿童传染病学会（PIDS）对抗菌药物管理的政策声明。
Infect Control Hosp Epidemiol. 2012 Apr;33(4):322-7. doi: 10.1086/665010.
10
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.美国传染病学会和美国医疗保健流行病学学会关于制定机构计划以加强抗菌药物管理的指南。
Clin Infect Dis. 2007 Jan 15;44(2):159-77. doi: 10.1086/510393. Epub 2006 Dec 13.
Zotero 插件